Objective: To determine the prevalence of fatty liver and alanine aminotransferase (ALT) elevation in obese Japanese women and to clarify the factors contributing to fatty change and ALT elevation in the cohort. Design: Cross-sectional and population-based study. Subjects: From 4366 women who received their annual health check-up, 4211 women were selected for analysis. All 4211 women were negative for hepatitis virus markers. Measurements: Peripheral blood cell counts, liver biochemical tests, fasting glucose, cholesterol and triglyceride levels, uric acids, glycosylate hemoglobin A1c, and ultrasound examination. Results: Ultrasonographic evidence of fatty liver and ALT elevation was seen in 391 (9.3%) and 238 (5.7%), respectively, of the 4211 women. Frequencies of both fatty liver and ALT elevation increased with increase in the degree of obesity. The frequency of ALT elevation was higher in women with fatty liver than in women without fatty liver among the nonobese or mildly obese group. However, the frequency of ALT elevation was not significantly different between women with fatty liver and women without fatty liver among the severely obese group. Multivariate analysis showed that obesity, hemoglobin (Z14 g/dl), triglyceride (Z150 mg/dl), diabetes mellitus, and fatty liver were significant predictors of ALT elevation. However, only two variables, hemoglobin (Z14 g/dl) and presence of diabetes, were significant in the severely obese group. Conclusions: ALT elevation not associated with fatty liver was frequently seen in obese women, suggesting that obesity is directly associated with the elevated ALT level in Japanese obese women. In addition, hemoglobin (Z14 g/dl) was a strong predictor of ALT elevation in the severely obese group.
Introduction
The prevalence of overweight persons is increasing in developed and developing countries (Kuczmarski et al, 1997; Kopelman, 2000; Hamaguchi & Sakata, 2001) . Fatty metamorphosis in the liver is common in these obese subjects and fatty liver has become prevalent with the epidemic of obesity (Falck-Ytter et al, 2001; Day, 2002) . In Japan, chronic liver disease in most patients is caused by hepatitis viruses type B or C (Nishioka et al, 1991; Yamada et al, 1995) . However, fatty liver has been recently increasing with increase in the prevalence of obesity, which is attributable to lifestyle change including physical inactivity and increase in daily fat consumption (Hamaguchi & Sakata, 2001) . Although fatty change in the liver is associated with elevated levels of alanine aminotransferase (ALT), the majority of persons with fatty liver detected by ultrasound examination show normal ALT levels (Yano et al, 2001; Sakugawa et al, 2003) .
Most fatty liver seen in ordinary women is not caused by alcohol, because women with a history of regular alcohol intake in Japan are rare (Nomura et al, 1998) . Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD), and is strongly associated with female gender, older age, obesity, and type II diabetes mellitus (Ludwig et al, 1980; Falck-Ytter et al, 2001; Day, 2002) (Sheth, 1997; Nomura et al, 1988) . Most patients with NASH are asymptomatic and have elevated liver enzyme levels (Bacon et al, 1994) . Few studies have been carried out on the prevalence of fatty liver or liver enzyme abnormality among larger populations of mild or moderately obese individuals. (Nomura et al, 1988; Day, 2002) .
The aims of the present study were to determine the prevalence of fatty liver and ALT elevation in obese Japanese women and to clarify the factors contributing to fatty change and ALT elevation in the cohort.
Subjects and methods
From January 2000 to December 2000, a total of 4366 healthy women received their health check-up at the Okinawa General Health Service Association. They were all Japanese living in the Okinawa Islands, Japan, aged between 21 and 88 y: 87% were 40 y of age or greater. It is of note that the health check-up was not mandatory and the women visited the health check-up of their own choice, and therefore, the sampling was not randomized.
For all women, the body mass index (BMI; kg/m 2 ) was calculated. Obesity was defined as BMIZ25 kg/m 2 as recommended by the Japan Society for Obesity (Yoshiike et al, 1998) . The women were divided into three groups: nonobese Laboratory tests included peripheral blood cell counts, liver function tests (aspartate aminotransferase, ALT, gglutamyl transpeptidase, alkaline phosphatase), fasting glucose, cholesterol and triglyceride levels, uric acid, glycosylated hemoglobin A1c (HbA1c), hepatitis B surface antigen (HBsAg), and antibody to hepatitis C virus (anti-HCV).
Standard liver tests were performed on a multichannel autoanalyzer. HBsAg was measured by a commercially available enzyme immunoassay (Enzygnost, Berling, Germany) . Anti-HCV was tested by a second-generation enzyme immunoassay (Ortho Diagnostics, Raritan, NJ, USA).
Diagnosis of fatty liver was made using ultrasound according to (Severtmuttu et al, 1986) . The criterion for fatty liver was hyperechoic liver tissue with fine, tightly packed echoes. The degree of fatty change was assessed by the fall in echo amplitude with depth, increasing discrepancy of echo amplitude between the liver and kidney, and loss of echoes from the wall of the portal veins.
The presence of diabetes mellitus was defined as fasting blood glucose Z126 mg/dl and/or HbA1c Z6.1. (The Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus, 1999; Takahashi et al, 2000) . The presence of high blood pressure was defined as systolic blood pressure Z140 mmHg and/or diastolic blood pressure Z90 mmHg.
The main end point was the identification of the presence or absence of elevated ALT level combined with clinically associated variables: age, BMI, and hypertension, hemoglobin, total cholesterol, triglyceride, uric acid, diabetes mellitus, fatty liver. All variables were included in a multivariate logistic regression analysis to find the independent predictors of the presence or absence of elevated ALT level.
The continuous variables were compared between the nonobese, mildly obese, and severely obese groups using the two-tailed Student's t-test. Correlation among these variables was analyzed by Pearson's correlation coefficient. Categorical variables were compared with Fisher's exact test. Multivariate analysis was tested using logistic regression analysis. The SPSS statistical software was used for statistical analysis. A Pvalue less than 0.05 was considered statistically significant.
Results
Among 4366 women who received a health check-up, 141 were positive for HBsAg and 14 were positive for anti-HCV (no one was positive for both HBsAg and anti-HCV together). Persons with either HBsAg or anti-HCV were excluded from this study; the data of the remaining 4211 women were used for the analysis.
Of the 4211 women without hepatitis virus markers, 238 (5.7%) showed an elevated ALT level. The ALT level and any of the following quantitative variables were significantly correlated: age, BMI, systolic blood pressure, hemoglobin, blood glucose level, HbA1c, total serum cholesterol, triglyceride and uric acid (by Pearson's correlation coefficient, data not shown). When classified into two categories (normal or abnormal, present or absent, above or below), eight variables were associated with ALT elevation (Table 1) .
Fatty liver was detected in 391 (9.3%) of the 4211 women by using ultrasound and its frequency increased with an increase in the degree of obesity (Table 2) . Among the 391 women with fatty liver, 66 (16.9%) showed elevated ALT levels, the frequency of which also increased with an increase in the degree of obesity, and 4.5% of women without fatty liver showed an ALT elevation, the frequency of which also increased with an increase in the degree of obesity. The frequency of ALT elevation was higher in women with fatty liver than in women without fatty liver in the nonobese group and the mildly obese group. However, the frequency of ALT elevation was not significantly different between women with fatty liver and women without fatty liver in the severely obese group (Table 2) .
Although eight clinical variables were associated with ALT elevation in univariate analysis (Table 1) , logistic regression analysis indicated that five out of the eight variables were significantly and independently associated with ALT elevation (Table 3) . To examine the effect of modification between obesity (BMI Z25) and the presence of fatty liver, the interaction term (obesity Â fatty liver) was included in the logistic model. There was no interaction between the obesity and the presence of fatty liver (Table 3) . The logistic regression analysis was also performed using variables other than BMI as independent predictors in each of the three groups (nonobese, mildly obese, and severely obese). The presence of fatty liver was independently associated with ALT elevation in the nonobese or mildly obese group. However, the association between the presence of fatty liver and ALT elevation was not seen in the severely obese group, and only two variables (hemoglobin and presence of diabetes) were significantly associated with ALT elevation in this group (Table 4) .
Clinical variables predicting the presence of ultrasonographic evidence of fatty liver were also examined by multivariate analysis. In all the women, five variables were Obesity and ALT elevation in Japanese women H Sakugawa et al independently associated with the presence of fatty liver: BMIZ25 (Po0.001), hemoglobin Z14 g/dl (P ¼ 0.002), AL-T440 IU/l (Po0.001), triglyceride Z150 mg/dl (Po0.001), and uric acid Z7.0 mg/dl (Po0.001).
Discussion
Obesity is associated with several clinical conditions: hypertension, hyperlipidemia, type II diabetes mellitus, fatty liver, etc. (De Fronzo & Ferrannini, 1991; Moller & Flier, 1991; (Kissebah & Krakower, 1994) . In this study, fatty liver was detected in 9.3% of normal adult women, most (83%) of whom showed normal ALT levels. Fatty liver is induced by abnormal lipid metabolism and is not necessarily accompanied by liver cell necrosis, which is associated with elevated ALT levels. NASH is a progressive type of NAFLD and is strongly associated with female gender, type II diabetes mellitus, and obesity (Ludwig et al, 1980; Sheth, 1997; Falck-Ytter et al, 2001; Day, 2002) . A two-hit theory was proposed for the pathogenesis of NASH: fat droplet accumulation in liver cells (first hit) followed by liver cell necrosis (second hit), which may be due to oxidative stress, mitochondrial dysfunction, or cytokine upregulation (Harrison et al, 2002) .
ALT elevation not associated with fatty liver was frequently seen in obese women, especially in the severely obese group. In addition, fatty liver was not a statistically independent predictor of ALT elevation in our severely obese women. The second hit may not necessary require the first hit as its precursor lesion. The second hit alone may exist particularly among obese women. Although lipid-accumulated hepatocytes are susceptible to a second-hit injury , oxidative stress or mitochondrial dysfunction may exist in the liver without underlying fatty change.
Obesity is strongly associated with the degree of insulin resistance, which increases the delivery of free fatty acids to the liver (Harrison et al, 2002 ). An increase in free fatty acids in the liver leads to the formation of free radicals . The formation of free radicals is also induced by iron overload (Bacon et al, 1993) , which is associated with insulin resistance (Mendler et al, 1998; Fargion et al, 2001) . Liver iron concentration is correlated with peripheral hemoglobin concentration (Bonkovsky et al, 1997; Fargion et al, 2001) . In this study, peripheral hemoglobin concentration was correlated with serum ALT level (r ¼ 0.219, Po0/ 001; data not shown) and BMI (r ¼ 0.147, Po0.001; data not shown). Obesity is associated with arterial hypoxemia, which may result from reduced pulmonary function (Luce, 1980; Ray et al, 1983) . Arterial hypoxemia is responsible for elevated hemoglobin concentration (Messinezy & Pearson, 1990) . Sleep apnea syndrome is frequently seen in obese persons (Messinezy & Pearson, 1990; Coughlin et al, 2001) , and is associated with hypoxemia and elevated levels of hemoglobin. Although the peripheral hemoglobin concentration was associated with obesity, the elevated hemoglobin concentration was independently associated with the ALT elevation, particularly in the severely obese women.
In NAFLD, the degree of fatty change may decrease as disease progresses (Falck-Ytter et al, 2001) . Severely obese women in this study frequently had elevated ALT levels not associated with fatty liver, and may have included more advanced disease. However, advanced disease such as cirrhosis is rarely encountered in general population studies. In addition, AST/ALT41, which is a marker of advanced fibrosis in NASH (Falck-Ytter et al, 2001) , was rarely seen in the severely obese group.
In this study, we enrolled only women, but the annual health check-ups include many men. General population studies from Japan showed that 73% of males in health check-ups drink alcohol and 12.5% of them drink more than 453 ml/week (Nomura et al, 1988; Yano et al, 2001) . To diagnose NAFLD, a strict history of habitual alcohol intake and less than 40 B210 g/week of average alcohol intake is necessary (Falck-Ytter et al, 2001) . Obtaining information of alcohol intake from family members who are in close contact with each subject is difficult in population-based studies. Most male health subjects may not fulfill the criteria for NAFLD because of habitual alcohol intake (Nomura et al, 1988) . We therefore excluded male health subjects from this study to minimize the possibility of including alcoholrelated liver disease. Most female health subjects had no regular alcohol intake. We previously interviewed 128 female health subjects who had elevated ALT level and only one (0.8%) of them had a history of regular alcohol intake. The subjects of this study may have included some women with a history of regular alcohol intake, but the influence of alcohol may have been quite small and may not have affected the whole data.
In conclusion, ALT elevation not associated with fatty liver was frequently seen in obese women, especially in severely obese women, suggesting that obesity is directly, not indirectly through fatty liver, associated with the elevated ALT level in Japanese women. In the severely obese women, only hemoglobin Z14 g/dl and diabetic state were independently associated with ALT elevation.
